Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated just now
Peer-reviewedCC BY-NC-ND 4.0Molecular Medicine

Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways

4 more authors
9 affiliations
  1. 1Departamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico
  2. 2Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City, Mexico
  3. 3Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  4. 4Unidad de Investigación Médica en Medicina Reproductiva, UMAE, Hospital de Gineco-Obstetricia no. 4 “Luis Castelazo Ayala”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
  5. 5SECIHTI- Hospital Infantil de México Federico Gómez, Mexico City, Mexico
  6. 6Subdirección de Investigación Biomédica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico
  7. 7Departamento de Ginecología y Obstetricia, Hospital Ángeles México, Mexico City, Mexico
  8. 8Ginecología y Obstetricia, Hospital Ángeles Lomas – UNAM, Huixquilucan, Mexico
  9. 9Dirección de Investigación, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico

Abstract

Background: Exposure to elevated glucose levels during intrauterine life is detrimental to both the mother and fetus. As a glucose-sensitive organ, the placenta responds to hyperglycemia by mounting a pro-inflammatory response characterized by increased production of inflammatory mediators that disrupt the immune privilege of the maternal-fetal interface. Although hyperglycemia promotes inflammation in human placental tissue, the molecular mechanisms through which HMGB1 release and advanced glycation end products (AGEs) accumulation converge on RAGE-associated signaling pathways to sustain this response remain poorly understood.

Objective: To investigate the molecular mechanisms by which hyperglycemia activates HMGB1/AGEs-dependent signaling networks leading to inflammatory responses in human placental villi.

Methods: Human term placental villous explants were exposed to normal or high glucose concentrations for 1–9 h or 48 h. For pathway inhibition experiments, explants were treated with selective inhibitors during high-glucose exposure. Inflammatory mediators, extracellular HMGB1, glyoxal-derived AGEs, TLR4 and RAGE expression, and activation of Akt1, ERK1/2, and NF-κB were evaluated.

Results: High-glucose exposure elicited a pro-inflammatory phenotype characterized by increased extracellular HMGB1 release, enhanced glyoxal-derived AGEs formation, and elevated TLR4 expression, supporting the involvement of HMGB1/AGE-RAGE signaling. Mechanistically, hyperglycemia was associated with activation of the PI3K/Akt and MAPK/ERK1/2 pathways, promoting NF-κB activation, suggesting the participation of both RAGE-dependent and RAGE-independent mechanisms, leading to increased secretion of TNF-α, IL-1β, and IL-6. Pharmacological inhibition experiments suggested the existence of putative interconnected positive feedback loops linking AGE accumulation, HMGB1 release, RAGE activation, and downstream inflammatory signaling, supporting the establishment of a self-sustaining metainflammatory network in placental villi.

Conclusions: Collectively, these findings provide insight into the mechanisms by which sustained maternal hyperglycemia reshapes placental immune signaling and promotes a chronic metainflammatory state that may compromise placental function. Our results support a mechanistic model in which HMGB1/AGE-RAGE/TLR4 signaling contributes to placental dysfunction during gestational hyperglycemia.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s10020-026-01604-3.

Related

  1. Early diagnosis of capivasertib-associated severe hyperglycemia with diabetic ketosis diagnosed in routine clinical practice: a case report with review of literature
    Masashi Yoshikawa, Keiichiro Takahashi, Satoshi Yoshino +9
    Endocrine JournalPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationJ-STAGEPMC
  2. Hyperglycemia-Induced Loss of Astrocytic Kir4.1 Is Associated with Increased DNMT1 Activity and Altered AMPK/SIRT1 Signaling
    Jadier Colón-Vázquez, Yanitza Hernández-Santiago, Christian J. Malpica-Nieves +8
    CellsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  3. Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice
    Cuiying Xiao, Rui-Hong Wang, Tyler Lahusen +10
    Journal of Biological ChemistryPeer-reviewedCC BYFull text156 citedMolecular biology & gene regulationHAL
  4. Metabolomics identifies endocannabinoid system remodeling during obesity associated inflammation in adipose tissue
    N. Bararpour, A. Thomas, F. Gilardi +5
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  5. Optimized Super-SILAC Normalization Enables Enhanced Profiling of Histone Post-Translational Modification Changes Associated with Microbiota and Acute Inflammation
    Dieggo Rodrigues de Paula, Alessandro Vai, Roberta Noberini +5
    Molecular & Cellular ProteomicsPeer-reviewedLicence not statedProteomics & metabolomicsCrossref
BibTeX
@article{vargasalcantar2026hyperglycemiainduced,
  title = {{Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways}},
  author = {Donovan Vargas-Alcantar and Karina Martínez-Garfias and Karla Hernández-Bones and Rodrigo Jiménez-Escutia and Samara Rodríguez-Flores and Eulises Díaz-Díaz and Aleida Olivares and Lourdes Alvarez-Arellano and Consuelo Lomas-Soria and Ismael Mancilla-Herrera and Pilar Velázquez-Sánchez and Rodrigo Zamora-Escudero and Paloma Cervantes-Delgado and Lorenza Díaz and Verónica Zaga-Clavellina and Andrea Olmos-Ortiz},
  journal = {Molecular Medicine},
  year = {2026},
  month = aug,
  doi = {10.1186/s10020-026-01604-3},
  url = {https://doi.org/10.1186/s10020-026-01604-3},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways
AU  - Donovan Vargas-Alcantar
AU  - Karina Martínez-Garfias
AU  - Karla Hernández-Bones
AU  - Rodrigo Jiménez-Escutia
AU  - Samara Rodríguez-Flores
AU  - Eulises Díaz-Díaz
AU  - Aleida Olivares
AU  - Lourdes Alvarez-Arellano
AU  - Consuelo Lomas-Soria
AU  - Ismael Mancilla-Herrera
AU  - Pilar Velázquez-Sánchez
AU  - Rodrigo Zamora-Escudero
AU  - Paloma Cervantes-Delgado
AU  - Lorenza Díaz
AU  - Verónica Zaga-Clavellina
AU  - Andrea Olmos-Ortiz
PY  - 2026
DA  - 2026/08/01
JO  - Molecular Medicine
DO  - 10.1186/s10020-026-01604-3
UR  - https://doi.org/10.1186/s10020-026-01604-3
AB  - Background: Exposure to elevated glucose levels during intrauterine life is detrimental to both the mother and fetus. As a glucose-sensitive organ, the placenta responds to hyperglycemia by mounting a pro-inflammatory response characterized by increased production of inflammatory mediators that disrupt the immune privilege of the maternal-fetal interface. Although hyperglycemia promotes inflammation in human placental tissue, the molecular mechanisms through which HMGB1 release and advanced glycation end products (AGEs) accumulation converge on RAGE-associated signaling pathways to sustain this response remain poorly understood.  Objective: To investigate the molecular mechanisms by which hyperglycemia activates HMGB1/AGEs-dependent signaling networks leading to inflammatory responses in human placental villi.  Methods: Human term placental villous explants were exposed to normal or high glucose concentrations for 1–9 h or 48 h. For pathway inhibition experiments, explants were treated with selective inhibitors during high-glucose exposure. Inflammatory mediators, extracellular HMGB1, glyoxal-derived AGEs, TLR4 and RAGE expression, and activation of Akt1, ERK1/2, and NF-κB were evaluated.  Results: High-glucose exposure elicited a pro-inflammatory phenotype characterized by increased extracellular HMGB1 release, enhanced glyoxal-derived AGEs formation, and elevated TLR4 expression, supporting the involvement of HMGB1/AGE-RAGE signaling. Mechanistically, hyperglycemia was associated with activation of the PI3K/Akt and MAPK/ERK1/2 pathways, promoting NF-κB activation, suggesting the participation of both RAGE-dependent and RAGE-independent mechanisms, leading to increased secretion of TNF-α, IL-1β, and IL-6. Pharmacological inhibition experiments suggested the existence of putative interconnected positive feedback loops linking AGE accumulation, HMGB1 release, RAGE activation, and downstream inflammatory signaling, supporting the establishment of a self-sustaining metainflammatory network in placental villi.  Conclusions: Collectively, these findings provide insight into the mechanisms by which sustained maternal hyperglycemia reshapes placental immune signaling and promotes a chronic metainflammatory state that may compromise placental function. Our results support a mechanistic model in which HMGB1/AGE-RAGE/TLR4 signaling contributes to placental dysfunction during gestational hyperglycemia.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s10020-026-01604-3.
SN  - 1076-1551
SN  - 1528-3658
ER  -